We are live on
!
Find out more
TCM
Tao Capital Management Portfolio holdings
AUM
$119M
1-Year Est. Return
87.46%
This Fund
S&P 500
This Quarter
Est. Return
+0.25%
1 Year Est. Return
+87.46%
3 Year Est. Return
+356.21%
5 Year Est. Return
+280.73%
10 Year Est. Return
–
AUM
$106M
AUM Growth
-$3.77M
(-3.4%)
Cap. Flow
-$120K
Cap. Flow
% of AUM
-0.11%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
12
New
–
Increased
–
Reduced
–
Closed
2
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Denali Therapeutics
DNLI
|
+$66K |
| 2 |
Scholar Rock
SRRK
|
+$54K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 66.02% |
| 2 | Consumer Discretionary | 25.18% |
| 3 | Technology | 8.47% |
| 4 | Consumer Staples | 0.34% |
Similar funds
SF
MWM
VA
HPM
SKK
WKSWA
CA
LC
Tao Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Tao Capital Management held 12 positions worth $106M, down 3.4% from $109M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Tao Capital Management's Q1 2024 filing shows 2 closed positions. The largest sale was Denali Therapeutics, an estimated $66K.
By sector, the portfolio is most concentrated in Healthcare at 66% of assets, up from 64% a quarter earlier, followed by Consumer Discretionary and Technology.
- Tao Capital Management fully exited Denali Therapeutics in Q1 2024, selling an estimated $66K.
- Tao Capital Management's ten largest holdings make up 100% of its $106M portfolio in Q1 2024.
- Tao Capital Management opened 0 new positions and closed 2 in Q1 2024.
- Tao Capital Management's portfolio value fell 3.4% quarter-over-quarter to $106M.
Based on Tao Capital Management's 13F filing for Q1 2024, filed 9 May 2024.